The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
Official Title: A Randomized, Double-blinded, Placebo-controlled, and Multi-centered Clinical Trial Evaluating the Efficacy and Safety of Tacrolimus Capsule in Myasthenia Gravis That Was Insufficiently Treated by Glucocorticoid Therapy
Study ID: NCT01325571
Brief Summary: To evaluate the efficacy and safety of tacrolimus capsules in patients with myasthenia gravis who are inadequately treated by glucocorticoid.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
, Beijing, , China
, Guangdong, , China
, Jiangsu, , China
, Jilin, , China
, Shandong, , China
, Shanghai, , China
, Sichuan, , China
, Wuhan, , China
, Zhejiang, , China
Name: Use Central Contact
Affiliation: Astellas Pharma Inc
Role: STUDY_CHAIR